Molecular Bases of Cutaneous and Uveal Melanomas

por Gaudi, Sudeep, Messina, Jane L.
Publicado 2011

BRAF inhibition generates a host/tumor niche that mediates therapeutic escape

por Fedorenko, Inna V., Wargo, Jennifer A., Flaherty, Keith T., Messina, Jane L., Smalley, Keiran S.M.
Publicado 2015

Comparing whole slide digital images versus traditional glass slides in the detection of common microscopic features seen in dermatitis

por Vyas, Nikki S., Markow, Michael, Prieto-Granada, Carlos, Gaudi, Sudeep, Turner, Leslie, Rodriguez-Waitkus, Paul, Messina, Jane L., Jukic, Drazen M.
Publicado 2016

Clinicopathologic Predictors of Survival in Patients with Desmoplastic Melanoma

por Han, Dale, Han, Gang, Zhao, Xiuhua, Rao, Nikhil G., Messina, Jane L., Marzban, Suroosh S., Sarnaik, Amod A., Cruse, C. Wayne, Sondak, Vernon K., Zager, Jonathan S.
Publicado 2015

Performance of a 31‐gene expression profile test in cutaneous melanomas of the head and neck

por Gastman, Brian R., Zager, Jonathan S., Messina, Jane L., Cook, Robert W., Covington, Kyle R., Middlebrook, Brooke, Gerami, Pedram, Wayne, Jeffrey D., Leachman, Sancy, Vetto, John T.
Publicado 2019

12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?

por Messina, Jane L., Fenstermacher, David A., Eschrich, Steven, Qu, Xiaotao, Berglund, Anders E., Lloyd, Mark C., Schell, Michael J., Sondak, Vernon K., Weber, Jeffrey S., Mulé, James J.
Publicado 2012

XL888 limits vemurafenib-induced proliferative skin events by suppressing paradoxical MAPK activation

por Phadke, Manali, Gibney, Geoffrey T., Rich, Carolyn J., Fedorenko, Inna V., Chen, Y. Ann, Kudchadkar, Ragini R., Sondak, Vernon K., Weber, Jeffrey, Messina, Jane L., Smalley, Keiran S. M.
Publicado 2015

Grade of Primary Cutaneous Leiomyosarcoma Dictates Risk for Metastatic Spread and Disease-Specific Mortality

por Carr, Michael J., Sun, James, Adams, William A., Dugan, Michelle M., Naqvi, Syeda M. H., Kim, Youngchul, Messina, Jane L., Gonzalez, Ricardo J., Zager, Jonathan S., Mullinax, John E.
Publicado 2023

Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins

por Weitman, Evan S, Perez, Matthew C, Lee, Daniel, Kim, Youngchul, Fulp, William, Sondak, Vernon K, Sarnaik, Amod A, Gonzalez, Ricardo J, Cruse, Carl W, Messina, Jane L, Zager, Jonathan S
Publicado 2019

Metabolomics of primary cutaneous melanoma and matched adjacent extratumoral microenvironment

por Taylor, Nicholas J., Gaynanova, Irina, Eschrich, Steven A., Welsh, Eric A., Garrett, Timothy J., Beecher, Chris, Sharma, Ritin, Koomen, John M., Smalley, Keiran S. M., Messina, Jane L., Kanetsky, Peter A.
Publicado 2020

Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin – a case–control study

por Iannacone, Michelle R, Wang, Wei, Stockwell, Heather G, O’Rourke, Kathleen, Giuliano, Anna R, Sondak, Vernon K, Messina, Jane L, Roetzheim, Richard G, Cherpelis, Basil S, Fenske, Neil A, Rollison, Dana E
Publicado 2012

Circulating Immunosuppressive Regulatory T Cells Predict Risk of Incident Cutaneous Squamous Cell Carcinoma

por Rollison, Dana E., Messina, Jane L., Cherpelis, Basil S., Fenske, Neil A., Schell, Michael J., Adeegbe, Dennis O., Zhao, Yayi, Amorrortu, Rossybelle P., Akuffo, Afua A., Hesterberg, Rebecca S., Epling-Burnette, Pearlie K.
Publicado 2021

Atypical Fibroxanthoma: Outcomes from a Large Single Institution Series

por McClure, Erin, Carr, Michael J, Patel, Ayushi, Hussnain Naqvi, Syed Mahrukh, Kim, Youngchul, Harrington, Michael, Cruse, Wayne, Gonzalez, Ricardo J, Sondak, Vernon K, Sarnaik, Amod A, Messina, Jane L, Zager, Jonathan S
Publicado 2023

Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience

por Oliver, Daniel E, Sondak, Vernon K, Strom, Tobin, Zager, Jonathan S, Naghavi, Arash O, Sarnaik, Amod, Messina, Jane L, Caudell, Jimmy J, Trotti, Andy M, Torres-Roca, Javier F, Khushalani, Nikhil I, Harrison, Louis B
Publicado 2018

Combined Analysis of Phase III Trials Evaluating [(99m)Tc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneous Melanoma

por Sondak, Vernon K., King, Dennis W., Zager, Jonathan S., Schneebaum, Schlomo, Kim, Julian, Leong, Stanley P. L., Faries, Mark B., Averbook, Bruce J., Martinez, Steve R., Puleo, Christopher A., Messina, Jane L., Christman, Lori, Wallace, Anne M.
Publicado 2012

Cutaneous viral infections associated with ultraviolet radiation exposure

por Zhao, Yayi, Amorrortu, Rossybelle P., Fenske, Neil A., Cherpelis, Basil, Messina, Jane L., Sondak, Vernon K., Giuliano, Anna R., Schell, Michael J., Waterboer, Tim, Pawlita, Michael, McKay‐Chopin, Sandrine, Gheit, Tarik, Tommasino, Massimo, Rollison, Dana E.
Publicado 2020

GSK3β inhibition blocks melanoma cell/host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation

por John, Jobin K., Paraiso, Kim H.T., Rebecca, Vito W., Cantini, Liliana P., Abel, Ethan V., Pagano, Nicholas, Meggers, Eric, Mathew, Rahel, Krepler, Clemens, Izumi, Victoria, Fang, Bin, Koomen, John M., Messina, Jane L., Herlyn, Meenhard, Smalley, Keiran S. M.
Publicado 2012

Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation

por Sung, Hyeran, Kanchi, Krishna L., Wang, Xue, Hill, Kristen S., Messina, Jane L., Lee, Ji-Hyun, Kim, Youngchul, Dees, Nathan D., Ding, Li, Teer, Jamie K., Yang, Shengyu, Sarnaik, Amod A., Sondak, Vernon K., Mulé, James J., Wilson, Richard K., Weber, Jeffrey S., Kim, Minjung
Publicado 2016

Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells

por Fedorenko, Inna V., Abel, Ethan V., Koomen, John M., Fang, Bin, Wood, Elizabeth R., Chen, Y. Ann, Fisher, Kate J., Iyengar, Sanjana, Dahlman, Kimberly B., Wargo, Jennifer A., Flaherty, Keith T., Sosman, Jeffrey A., Sondak, Vernon K., Messina, Jane L., Gibney, Geoffrey T., Smalley, Keiran S.M.
Publicado 2015

Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma

por Smalley, Inna, Kim, Eunjung, Li, Jiannong, Spence, Paige, Wyatt, Clayton J., Eroglu, Zeynep, Sondak, Vernon K., Messina, Jane L., Babacan, Nalan Akgul, Maria-Engler, Silvya Stuchi, De Armas, Lesley, Williams, Sion L., Gatenby, Robert A., Chen, Y. Ann, Anderson, Alexander R.A., Smalley, Keiran S.M.
Publicado 2019